POST MARKET SAFETY SURVEILLANCE

Jeffrey R Curtis, Nivedita Patkar, Aiyuan Xie, Carolyn Martin,Jeroan J Allison, Michael Saag, Deborah Shatin, and Kenneth G Saag. (2007). “Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists.” Arthritis & Rheumatism. 56(4): 1125-1133.

Deborah Shatin, Nigel S B Rawson and Andy Stergachis. (2005). “UnitedHealth Group,” Chapter 17 in B. L. Strom (ed). Pharmacoepidemiology (4th Edition). Sussex: John Wiley.

David J Graham, Judy A Staffa, Deborah Shatin, Susan E Andrade, Stephanie D Schech, Lois La Grenade, Jerry H Gurwitz, K Arnold Chan, Michael J Goodman, and Richard Platt. (2004). “Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.” JAMA. 292(21):2585-2590.

David J Graham, Carol Drinkard, and Deborah Shatin. (2003). “Incidence of Idiopathic acute liver failure and hospitalized liver injury in patients treated with Troglitazone.” American Journal of Gastroenterology. 98(1):175-179.